We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
New
Gold Supplier
Centrifuge
Multifuge X4 Pro Centrifuge Series
New
Silver Supplier
Quality Control Material
Multichem U
New
Automated Urinalysis Solution
DxU Iris Workcell
New
Respiratory Multiplex RT-PCR Kit
Respiratory Multiplex RT-PCR Kit
Visit expo >

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.
27 Oct 2021 - 29 Oct 2021

Image: Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is caused by a build-up of fatty deposits and fibrous tissue on the right ventricle, the chamber of the heart that pumps blood into the lungs (Photo courtesy of National Heart Foundation of Australia)

Novel Cardiovascular Biomarker Secretoneurin Implicated in Arrhythmogenesis

Secretoneurin is a 33-amino acid peptide derived from neuroendocrine and myocardial tissue that belongs to the granin protein family. Secretoneurin may play a role in regulating processes in the myocardium, including cardiomyocyte Ca2+ handling, and has been implicated in arrhythmogenesis. More...
21 Oct 2021
Image: Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is caused by a build-up of fatty deposits and fibrous tissue on the right ventricle, the chamber of the heart that pumps blood into the lungs (Photo courtesy of National Heart Foundation of Australia)

Novel Cardiovascular Biomarker Secretoneurin Implicated in Arrhythmogenesis

Secretoneurin is a 33-amino acid peptide derived from neuroendocrine and myocardial tissue that belongs to the granin protein family. Secretoneurin may play a role in regulating processes in the myocardium, including cardiomyocyte Ca2+ handling, and has been implicated in arrhythmogenesis. More...
21 Oct 2021
Illustration

Sysmex Inostics Launches New Ultra-Sensitive Leukemia Blood Test for Early Detection of Cancer Cells Following Initial Therapy

Sysmex Inostics (Baltimore, MD, USA) has developed a new CLIA-validated liquid biopsy test for the detection of Minimal Residual Disease (MRD) in Acute Myeloid Leukemia (AML) to better help in the fight against cancer. More...
21 Oct 2021
Illustration

Sysmex Inostics Launches New Ultra-Sensitive Leukemia Blood Test for Early Detection of Cancer Cells Following Initial Therapy

Sysmex Inostics (Baltimore, MD, USA) has developed a new CLIA-validated liquid biopsy test for the detection of Minimal Residual Disease (MRD) in Acute Myeloid Leukemia (AML) to better help in the fight against cancer. More...
21 Oct 2021
Image: QIAreach QuantiFERON-TB (Photo courtesy of QIAGEN N.V.)

Qiagen Launches Novel Tuberculosis Blood Test That Marks Quantum Leap from Traditional TB Skin Test

QIAGEN N.V. (Venlo, Netherlands) has announced the launch and CE marking of QIAreach QuantiFERON-TB test for tuberculosis (TB) infection, in order to help achieve global TB elimination targets by increasing access to easy and reliable TB testing, especially in high burden countries, low-resource regions. More...
21 Oct 2021
Image: QIAreach QuantiFERON-TB (Photo courtesy of QIAGEN N.V.)

Qiagen Launches Novel Tuberculosis Blood Test That Marks Quantum Leap from Traditional TB Skin Test

QIAGEN N.V. (Venlo, Netherlands) has announced the launch and CE marking of QIAreach QuantiFERON-TB test for tuberculosis (TB) infection, in order to help achieve global TB elimination targets by increasing access to easy and reliable TB testing, especially in high burden countries, low-resource regions. More...
21 Oct 2021
Image: The Saliva Glucose Biosensor (Photo courtesy of GBS, Inc.)

Real-Time Glucose Saliva-Based Test to Replace Invasive Finger-Prick Testing for Diabetic Patients

A non-invasive, real-time saliva-based glucose test for patients and their primary health practitioners at point-of-care could provide people living with diabetes a more favorable solution to finger-prick blood glucose testing. More...
21 Oct 2021
Copyright © 2000-2021 Globetech Media. All rights reserved.